Christiana Stamoulis - Net Worth and Insider Trading
Christiana Stamoulis Net Worth
The estimated net worth of Christiana Stamoulis is at least $16 Million dollars as of 2023-03-28. Christiana Stamoulis is the SVP, Corp Strategy & Bus Devlp of Vertex Pharmaceuticals Inc and owns about 41,651 shares of Vertex Pharmaceuticals Inc (VRTX) stock worth over $13 Million. Christiana Stamoulis is also the Director of Hologic Inc and owns about 39,392 shares of Hologic Inc (HOLX) stock worth over $3 Million. Details can be seen in Christiana Stamoulis's Latest Holdings Summary section.
Transaction Summary of Christiana Stamoulis
Christiana Stamoulis Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christiana Stamoulis owns 4 companies in total, including Incyte Corp (INCY) , Hologic Inc (HOLX) , and Cogent Biosciences Inc (COGT) among others .
Click here to see the complete history of Christiana Stamoulis’s form 4 insider trades.
Insider Ownership Summary of Christiana Stamoulis
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| INCY | Incyte Corp | 2019-02-11 | EVP & Chief Financial Officer |
| HOLX | Hologic Inc | 2011-11-01 | director |
| COGT | Cogent Biosciences Inc | 2018-03-28 | President & C.F.O. |
| VRTX | Vertex Pharmaceuticals Inc | 2010-10-06 | SVP & Corp Strategy & Bus Devlp |
Christiana Stamoulis Latest Holdings Summary
Christiana Stamoulis currently owns a total of 2 stocks. Among these stocks, Christiana Stamoulis owns 41,651 shares of Vertex Pharmaceuticals Inc (VRTX) as of July 15, 2013, with a value of $13 Million and a weighting of 80.77%. Christiana Stamoulis also owns 39,392 shares of Hologic Inc (HOLX) as of November 4, 2020, with a value of $3 Million and a weighting of 19.23%.
Latest Holdings of Christiana Stamoulis
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Inc | 2013-07-15 | 41,651 | 313.25 | 13,047,176 |
| HOLX | Hologic Inc | 2020-11-04 | 39,392 | 78.84 | 3,105,468 |
Holding Weightings of Christiana Stamoulis
Christiana Stamoulis Form 4 Trading Tracker
According to the SEC Form 4 filings, Christiana Stamoulis has made a total of 0 transactions in Vertex Pharmaceuticals Inc (VRTX) over the past 5 years. The most-recent trade in Vertex Pharmaceuticals Inc is the sale of 1,125 shares on July 15, 2013, which brought Christiana Stamoulis around $97,144.
According to the SEC Form 4 filings, Christiana Stamoulis has made a total of 4 transactions in Hologic Inc (HOLX) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Hologic Inc is the sale of 11,146 shares on November 4, 2020, which brought Christiana Stamoulis around $824,804.
Insider Trading History of Christiana Stamoulis
- 1
Christiana Stamoulis Trading Performance
Christiana Stamoulis Ownership Network
Ownership Network List of Christiana Stamoulis
Ownership Network Relation of Christiana Stamoulis
Christiana Stamoulis Owned Company Details
What does Incyte Corp do?
Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes a broad array of oncology and dermatology programs.
Who are the key executives at Incyte Corp?
Christiana Stamoulis is the EVP & Chief Financial Officer of Incyte Corp. Other key executives at Incyte Corp include Principal Accounting Officer Thomas Tray , EVP & Head of Tech. Operations Michael James Morrissey , and EVP & General Manager & Europe Jonathan Elliott Dickinson .
Incyte Corp (INCY) Insider Trades Summary
Over the past 18 months, Christiana Stamoulis made no insider transaction in Incyte Corp (INCY). Other recent insider transactions involving Incyte Corp (INCY) include a net purchase of 2,510,403 shares made by Baker Bros. Advisors Lp , a net sale of 30,111 shares made by Vijay K Iyengar , and a net sale of 46,866 shares made by Barry P Flannelly .
In summary, during the past 3 months, insiders sold 97,842 shares of Incyte Corp (INCY) in total and bought 0 shares, with a net sale of 97,842 shares. During the past 18 months, 209,240 shares of Incyte Corp (INCY) were sold and 2,510,403 shares were bought by its insiders, resulting in a net purchase of 2,301,163 shares.
Incyte Corp (INCY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Incyte Corp Insider Transactions
Christiana Stamoulis Mailing Address
Above is the net worth, insider trading, and ownership report for Christiana Stamoulis. You might contact Christiana Stamoulis via mailing address: C/o Vertex Pharmaceuticals Incorporated, 130 Waverly St, Cambridge Ma 02139.
